Cell Therapeutics (CTIC) to Sell 40k Shares of Convertible Preferred Stock
Tweet Send to a Friend
Cell Therapeutics, Inc. (Nasdaq: CTIC) today announced that it intends to offer and sell 40,000 shares of its Series 17 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
